Table 3.
CBD-rich products at baseline (n = 279) | THC:CBD-balanced products at FUP1 (n = 104) | THC-rich products at FUP1 (n = 12) | ||||
---|---|---|---|---|---|---|
THC | CBD | THC | CBD | THC | CBD | |
Oil products (in mg/ml) | 0.1–2.0 | 2.0–52.0 | 0.6–30 | 2.5–39 | 1.25–45 | 0–18 |
Dried flower (in % w/w) | 0.7 | 17.0 | 3.7–9 | 7.7–13.4 | 13–27 | 0–0.5 |
Average daily dose (mg) | 0.5 | 11.47 | 19.65 | 26.32 | 54.28 | 10.80 |
Standard deviation (mg) | 0.43 | 10.21 | 5.80 | 9.12 | 29.65 | 7.64 |
Maximum daily dose (mg) | 6 | 156 | 60 | 78 | 90 | 54 |
Data comes from our sample of 279 patients
CBD cannabidiol, THC Δ9-tetrahydrocannabinol